Marquette Asset Management, LLC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 98 filers reported holding UTAH MED PRODS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Marquette Asset Management, LLC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q1 2022$24,000
-7.7%
2630.0%0.01%
+20.0%
Q4 2021$26,000
+8.3%
2630.0%0.01%0.0%
Q3 2021$24,000
+9.1%
2630.0%0.01%0.0%
Q2 2021$22,000
-4.3%
2630.0%0.01%
-16.7%
Q1 2021$23,000
+4.5%
2630.0%0.01%
+20.0%
Q4 2020$22,000
+4.8%
2630.0%0.01%
-16.7%
Q3 2020$21,000
-8.7%
2630.0%0.01%
-14.3%
Q2 2020$23,000
-8.0%
2630.0%0.01%
-30.0%
Q1 2020$25,000
-10.7%
2630.0%0.01%
+11.1%
Q4 2019$28,000
+12.0%
2630.0%0.01%
+12.5%
Q3 2019$25,0000.0%2630.0%0.01%0.0%
Q2 2019$25,000
+8.7%
2630.0%0.01%0.0%
Q1 2019$23,0002630.01%
Other shareholders
UTAH MED PRODS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Penn Mutual Asset Management 36,283$3,120,3382.93%
Clean Yield Group 31,263$2,684,5541.19%
BARD ASSOCIATES INC 18,181$1,563,5660.65%
RICE HALL JAMES & ASSOCIATES, LLC 111,634$9,600,5240.61%
Ranger Investment Management 74,411$6,399,3460.42%
ISTHMUS PARTNERS, LLC 21,307$1,832,4020.26%
Cardinal Capital Management 11,581$999,3440.20%
Riverwater Partners LLC 2,354$202,4440.18%
GLOBEFLEX CAPITAL L P 9,338$803,0680.09%
JAMES INVESTMENT RESEARCH INC 4,292$369,1120.05%
View complete list of UTAH MED PRODS INC shareholders